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Abstract
Author Manuscript

Prowashonupana barley (PWB) is high in β-glucan with moderate content of resistant starch. PWB
reduced intestinal fat deposition (IFD) in wild type Caenorhabditis elegans (C. elegans, N2), and
in sir-2.1 or daf-16 null mutants, and sustained a surrogate marker of lifespan, pharyngeal
pumping rate (PPR), in N2, sir-2.1, daf-16, or daf-16/daf-2 mutants. Hyperglycaemia (2% glucose)
reversed or reduced the PWB effect on IFD in N2 or daf-16/daf-2 mutants with a sustained PPR.
mRNA expression of cpt-1, cpt-2, ckr-1, and gcy-8 were dose-dependently reduced in N2 or
daf-16 mutants, elevated in daf-16/daf-2 mutants with reduction in cpt-1, and unchanged in sir-2.1
mutants. mRNA expressions were increased by hyperglycaemia in N2 or daf-16/daf-2 mutants,
while reduced in sir-2.1 or daf-16 mutants. The effects of PWB in the C. elegans model appeared
to be primarily mediated via sir-2.1, daf-16, and daf-16/daf-2. These data suggest that PWB and βglucans may benefit hyperglycaemia-impaired lipid metabolism.
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1. Introduction
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Obesity costs the US health care system over $100 billion a year and predisposes to diabetes
which generates even higher costs (Ogden et al., 2006). Only limited medications are
available to treat obesity, and surgical treatments are second-line obesity treatments. Diet
intervention, exercise, and lifestyle modification have been promoted by the National
Institutes of Health (NIH), the United States Department of Agriculture (USDA), and other
government institutions, but sustainable weight loss has been elusive. In an intensive diet
and behaviour modification program with meal replacements, adults lost 22.6–25.5+1% of
their body weight temporarily, but maintained only a 5% weight loss after 3 years (Kress,
Hartzell, Peterson, Williams, & Fagan, 2006; Wadden & Frey, 1997).
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Daily consumption of non-digestible fibre may offer a strategy to increase energy
expenditure and reduce body fat by stimulation of mitochondrial fat oxidation
(Chandrasekara & Shahidi, 2011; John & Shahidi, 2010; Madhujith, Amarowicz, & Shahidi,
2004). Average daily consumption of dietary fibre in the United States is currently 3 to 10 g/
day, 4 to 13 fold less than recommended (Anderson & Akanji, 1991; Goldring, 2004). Nondigestible carbohydrate, fermented to short chain fatty acids (SCFAs) in the lower
gastrointestinal tract, increases satiety hormone peptides YY (PYY) and glucagon-like
peptide-1 (GLP-1). These hormones augment fat oxidation (lower respiratory quotient),
elevate energy expenditure (Keenan et al., 2006; Zhou et al., 2006; Zhou et al., 2008), and
inhibit body fat accretion in rodents (Keenan et al., 2006; Shen et al., 2009). The most
efficient SCFA, butyrate, stimulates the production of PYY, GLP-1 (Zhou et al., 2006) and
prevents diet-induced insulin resistance which is directly related to a shorter lifespan in
mice, a reduced cell survival, and a decreased lifespan in the Caenorhabditis elegans (C.
elegans) model organism (Abate & Blackwell, 2009; Gao et al., 2009). A diet supplemented
with β-glucans at 4g/day for 14 weeks in 7 healthy overweight and obese subjects increased
fasting PYY, GLP-1, and increased post-meal satiety in humans (Greenway et al., 2007). We
found that fermentable carbohydrate or resistant starch (RS), endogenous gut fermentation
products of rodents fed RS, or the exogenous SCFA, butyrate, all reduce intestinal fat
deposition (IFD) in the wild type C. elegans (N2) (Zheng et al., 2010). The lipid oxidation
pathway including cluster differentiation transport protein (CD36), carnitine
palmitoyltranferase-1 (CPT-1), acetyl co-enzyme A carboxylase (ACC), and acetyl CoA
synthetase ACS have been identified using genetically manipulated C. elegans (see review
(Zheng & Greenway, 2012)).
Barley is the fourth most important cultivated foodstuff, and contains 62–77% starch (w/w)
which is composed of 25–35% atypical amylose starch with 3–5% RS type 3 (RS3) and βglucan (Asare et al., 2011; Vasanthan & Bhatty, 1998), a mixture that provides a distinctive
amylose-amylopectin interaction (Behall, Scholfield, & Hallfrisch, 2005; Dongowski, Huth,
Gebhardt, & Flamme, 2002; Lifschitz, Grusak, & Butte, 2002; Rendell et al., 2005; Tang,
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Ando, Watanabe, Takeda, & Mitsunaga, 2001). Barley also contains high levels of functional
lipids, such as, total phytosterols (1.2–9.6% of barley oil) and total tocotrienols (0.3–0.6% of
barley oil) which are 6–12 fold higher than in palm oil (0.05%) and 4–8 fold higher than in
rice bran oil (0.08%) (Moreau, Flores, & Hicks, 2007). The barley variety Prowashonupana
(PWB) contains 17% β-glucan and 15% fermentable starch (Rendell et al., 2005). These
carbohydrates delay or decrease the absorption of dietary fats and lower the postprandial
glycaemic response (Lifschitz et al., 2002). Dietary fermentable fibre such as RS is present
in a variety of cereals and offers the opportunity to reduce body fat and control body weight.
We demonstrated that RS type 2 (RS2) from corn (Ingredion Incorporated, Westchester, IL,
USA) induced a 23% reduction of intestinal fat deposition in wild type C. elegans (Zheng et
al., 2010). The specific PWB used in the present study has a lower RS content compared to
high amylose corn starch, but has significantly more soluble β-glucan than most other
barleys, which are linked to half of the PWB fibre (Behall et al., 2005; Rendell et al., 2005).
Retrograded amylose starch, RS type 3 (RS3), and β-glucan of PW barley provide distinctive
amylose–amylopectin and amylopectin-β-glucan interactions that increase the viscosity and
delay energy absorption in the GI tract (Asare et al., 2011; Moreau et al., 2007; Tang et al.,
2001; Vasanthan & Bhatty, 1998) reducing the glycaemic peak by 50%, lowering low
density lipoprotein (LDL) cholesterol in healthy humans, decreasing fat accumulation in
humans and rodents (Wursch & Pi-Sunyer, 1997), augmenting immunity by activating the
dectin-1 receptor and activating multiple genetic signalling pathways, including the DAF-2/
insulin-like receptor (ILR) pathways. The details of the mechanism by which insulinresistance is improved, however, are unclear (Engelmann & Pujol, 2011; Tsoni & Brown,
2008).
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C. elegans is a small, free-living soil nematode, a multicellular eukaryotic organism,
distributed widely around the world. C. elegans is the first animal to have its genome
completely sequenced and conserves 65% of the genes associated with human disease
(Zheng & Greenway, 2012). C. elegans dauer formation (daf) gene, daf-2, is a homolog of
the insulin and insulin-like growth factor (IGF) receptor in humans and is the only gene
encoding the insulin/IGF-1 like receptor in C. elegans (Zheng & Greenway, 2012).
Decreased daf-2 signalling increases C. elegans lifespan (Koga, Take-uchi, Tameishi, &
Ohshima, 1999; Kramer, Davidge, Lockyer, & Staveley, 2003) which fully depends upon
daf-16 (Patel et al., 2008), since daf-16 null mutations completely suppress the extension of
lifespan by daf-2 (e1370)III null mutant (Burks et al., 2000; Hertweck, Gobel, &
Baumeister, 2004; Hunt et al., 2011; Tissenbaum & Ruvkun, 1998; Yu et al., 2010).
Hyperglycaemia (2% glucose) causes insulin resistance in N2 and daf-2(e1370)III null
mutants, and reduces pharyngeal movement, a surrogate marker directly related to lifespan
(Abate & Blackwell, 2009). sir-2.1 overexpression prolongs C. elegans lifespan (Frojdo et
al., 2011). In fact, doubling C. elegans sir-2.1 gene number induces a 50% increase in the
lifespan that is DAF-16/FOXO dependent (Dorman, Albinder, Shroyer, & Kenyon, 1995;
Tissenbaum & Guarente, 2001), and the null mutant of sir-2.1(ok434)IV has a shorter
lifespan than the N2 (Gami & Wolkow, 2006), which recently became controversial, because
RNA interference (RNAi) did not suppress the longevity (Burnett et al., 2011). The gcy-8
gene (thermotaxis) is a subtype of guanylyl cyclase (GCYs) which has been proven to
promote fat storage and mediate satiety, as does cck.
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Two thirds of the genes associated with human diseases have homologs in C. elegans, and
the C. elegans intestine has similarities to the human gastrointestinal track (You, Kim,
Raizen, & Avery, 2008). Over 300 genes have been shown to cause a reduction in body fat
when inactivated, and inactivation of more than 100 genes has shown an increased fat
storage (Ashrafi et al., 2003). The genes governing lipid metabolism do not necessarily
overlap with genes governing the aging process (Zheng & Greenway, 2012). Not only does
the C. elegans model organism offer reduced costs when screening for bioactive substances,
the translucent bodies of the worms are convenient for analysis of intestinal fat deposition
(IFD) by lipid—staining dyes. Nile red fluorescent dye has been validated through lipidextraction, separation with thin layer chromatography, and quantification with gas
chromatography (Ashrafi et al., 2003). Recently, Nile red staining in vitro has been
recommended as being superior to coherent anti-Stokes Raman scattering (CARS)
microscopy (Yen et al., 2010).
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The goal of the current study was to determine the effects of PWB on IFD, insulinresistance, and hyperglycaemia-impaired lipid metabolism using the C. elegans N2, and null
mutants, sir-2.1(ok434)IV, daf-16(mgDf50)I, or daf-16(mgDf50)I;daf-2(m65) III.
Pharyngeal pumping rate (PPR), a surrogate marker of C. elegans lifespan (Chow, Glenn,
Johnston, Goldberg, & Wolkow, 2006; Finley et al., 2013), was also monitored to determine
effect of PWB on lifespan.

2. Material and methods

Author Manuscript

C. elegans strains and their standard lab food source, Escherichia coli (E. coli, OP50, Uracil
auxotroph), were provided by the Caenorhabditis Genetics Center (University of Minnesota,
Minneapolis, MN, USA). The C. elegans model is not regulated by the Institutional Animal
Care and Use Committees (IACUC) nor does it require IACUC approval (Zheng et al.,
2013).
2.1 Culture of E. coli (OP50)
OP50 were cultured by the standard method described elsewhere (Zheng et al., 2010).
Briefly, 10µl± of stock E. coli solution was added to Luria Broth (LB) medium and the
medium was incubated at 37°C for 48h. The OP50 were then sub-cultured in Petrifilm™
E.coli/Coliform Count Plates (3M Corporate, Minneapolis, MN, USA) at 37°C for 24h, and
the colonies of OP50 were confirmed to be at a density of 5×108 – 5×1011cfu/ml at which
time the C. elegans were allowed to eat ad libitum.
2.2 Culture of C. elegans

Author Manuscript

C. elegans N2, sir-2.1(ok434)IV, daf-16(mgDf50)I, and daf-16(mgDf50)I;daf-2(m65)III null
mutants were used in this study. Each strain was age synchronized, grown on Nematode
Growth Media (NGM) agar plates (Ø35 mm), transferred to a new dish every other day, and
stored in a low temperature incubator (Revco Tech., Nashville, NC, USA) at 20°C or 15°C
(daf-16(mgDf50)I;daf-2(m65)III) throughout the experiments. Mature gravid C. elegans
were transferred individually onto the agar plates and treated with a lysis solution consisting
of NaOH (1M, 500 µl, v/v) and sodium hypochlorite solution (5.25% , 200 µl, v/v) to
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dissolve the C. elegans body and to release the viable eggs. Stock solutions have been
previously described in detail. One day prior to the experiment, 200µl of a feeding media
containing E. coli was added to the agar dish.
2.3 Diet composition

Prowashonupana barley (Sustagrain®, Ardent Mills Corporate, Denver, CO, USA) were
powdered using a centrifugal mill with a 0.75mm sieve (Retsch ZM 200; Haan, Germany),
autoclaved at 121°C, and suspended in distilled deionized water (DDH2O; 5%, w/v).
Detailed nutritional data of PWB by Ardent Mills Corporate is listed in Table 1.

Author Manuscript

Control animals were fed with OP50 only. The experimental groups larval stage 2 (L2) were
fed supplementary Prowashonupana barley (PWB, 0.5, 1.0, or 3.0%) that had no additives.
To create insulin resistance, two percent glucose was added to an additional group of each
strain, with and without PWB (Table 2). The dietary nutrient composition is listed in Table 3
(Feijo Delgado et al., 2013). C. elegans were transferred to fresh dishes every other day
receiving treatment (50µl).
2.4 Pharyngeal movement (pumping rate, PPR)
Animals were examined periodically using a stereomicroscope (Nikon SMZ1500, Melville,
NY, USA) with transmitted light. The pharyngeal pumping rate (PPR) was recorded
manually by independent observers and the animals were returned to the incubators.
2.5 Fluorescence microscopy
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The lipophilic dye, Nile red, was selected to stain the intestinal fat deposition. Prior to fixing
the animals, an S-basal (see below) solution was added to the dish to wash the animals. The
solution containing the animals was centrifuged for 20 seconds at 805G and this procedure
was repeated twice. Animals were then fixed with 4% paraformaldehyde over 2h at 4°C and
washed with phosphate buffered saline (PBS) for 5 min × 3. Nile red (50 µl) was applied to
the specimens for 10 min. Ten microliters of Fluoromount-G (Southern Biotechnology
Associates, AL, USA) was applied to a glass slide followed by 20µl of the medium
containing Nile red stained animals. A cover glass was mounted on the glass slide. The
slides were viewed with an epifluorescence microscope (Nikon Eclipse, Ti) equipped with a
Texas Red filter. Fluorescent micrographs were taken with a digital camera (Andor,
DU-885k, Concord, MA, USA). The micrographs were analyzed using NIS elements
(Nikon). Line profiles of the optical densities (arbitrary units, % of control) of Nile red
labelled IFD were determined for adult animals (larval stage 4 [L4]).

Author Manuscript

2.6 Quantitative RT-PCR
2.6.1 Reagents—The Trizol® reagent (T9424), chloroform (C2432), and isopropanol
(I9516) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Taqman PCR core kit
(N8080228), MuLV Reverse Transcriptase (N8080018), and RNase Inhibitor (N8080119)
were obtained from Life Technologies (Grand Island, NY, USA). RNase-free micro tubes
and pipette tips were used in isolating RNA and in quantitative RT-PCR.
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2.6.2 RNA isolation—Total RNA was extracted using the Trizol® reagent as described
elsewhere (Ye, Gao, Yin, & He, 2007). C. elegans samples were homogenized in 1ml
Trizol® Reagent (Sigma-Aldrich, St. Louis, MO, USA) per 50–100 mg of tissue. The
samples went through 5 freeze-thaw cycles in which they were frozen in liquid nitrogen and
thawed in a 37°C water bath. The homogenized samples were vortexed at room temperature
to allow the complete dissociation of nucleoprotein complexes. Two hundred microliters of
cold pure chloroform per 1ml of Trizol® reagent were added and the samples were vortexed
for 15s before being incubated at room temperature for 5min. The samples were centrifuged
at 12,000g for 10 min at 4°C, and the top aqueous phase were transferred to a fresh tube. A
600µl aliquot of cold isopropanol per 1ml of Trizol® reagent was used for the initial
homogenization. The samples were then incubated at room temperature for 10min, vortexed
for 15s, and centrifuged at 12,000g for 10min at 4°C. The supernatant was removed and the
RNA pellet was washed once with 1ml cold 75% ethanol. The sample was vortexed and
centrifuged at 7,500g for 5min at 4°C. The supernatant was removed completely and the
RNA pellet was briefly air-dried. The RNA pellet was re-suspended in 0.1% diethyl
pyrocarbonate (DEPC)-treated water and stored at −80°C. The RNA concentration was
analysed with a Nanodrop® ND-1000 spectrophotometer (Wilmington, DE, USA).
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2.6.3 Quantitative RT-PCR—The mRNA levels of ckr-1, gcy-8, cpt-1, and cpt-2 were
determined using Taqman® quantitative RT-PCR. The following components were added in
one-step RT-PCR: 2.2µl H2O, 1µl 10× Taqman® buffer A, 2.2µl 25mM MgCl2 solution,
0.3µl 10mM dATP, 0.3µl 10mM dCTP, 0.3µl 10mM dGTP, 0.3µl 10mM dUTP, 0.05µl
20U/µl RNase inhibitor, 0.05µl 50U/µl MuLV reverse transcriptase, 0.05µl 5U/µl Amplitaq
gold®, 0.25µl Taqman® probe and primers, and 3µl 5ng/µl RNA. The PCR reaction was
conducted in triplicate using a Taqman® probe and primers set (Life Technologies) for
ckr-1(Ce02408606_m1), gcy-8(Ce02456184_g1), cpt-I(Ce02440434_m1), and
cpt-2(Ce02459919_g1). The mRNA signal was normalized over a eukaryotic 18S rRNA
(Hs99999901-s1) internal control. The reaction was conducted using a 7900 HT Fast realtime PCR system (Life Technologies). Reverse transcription was done at 48°C for 30min,
and AmpliTaq gold® activation (denaturation) was done at 95°C for 10min. Amplification of
the DNA involved 40 cycles of 15s at 95°C and 1min at 60°C. Data was analyzed using the
Sequence Detector Software (Life Technologies). The relative quantification of gene
expression (2−ΔΔCt) was calculated.
2.7 Statistical analysis

Author Manuscript

All data were presented as mean ± sem. Student t-test, analysis of variance (ANOVA) was
used for IFD, analysis of co-variance (ANCOVA) was used to compare the slopes of PPR
data, and principal component analyses (PCA) was conducted using SAS 9.4 (Cary, NC,
USA). Statistical significance was set at P≤0.05.

3. Results
Changes of IFD indicated by fluorescent intensity of Nile red and alterations in lifespan
suggested by reduced PPR indicating aging, with or without 2% glucose, were quantified in
this study. The IFD was reduced in N2, and null mutants of sir-2.1(ok434)IV and
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daf-16(mgDf50)I. These reductions were reversed in the presence of 2% glucose. The PPRs
declined in all groups as the animals aged. PWB treatment, however, increased the PPR in
all groups compared to their control that did not receive PWB treatment. These responses
were reversed in the presence of 2% glucose.
3.1 Intestinal fat deposition (IFD)
Post PWB treatment, the fluorescence intensity of Nile Red was dose-dependently reduced
by 19 to 44% (0.5 or 3.0%, n=6, P<0.05) in N2 (Fig. 1), by 18 to 28% (0.5, 1.0, or 3.0%,
n=9, P<0.01) in daf-16(mgDf50)I (Fig. 2b), or by 18 to 36% (0.5, 1.0, or 3.0%, n=9, P<0.01)
in the sir-2.1(ok434)IV (Fig. 2d). The reduction in daf-16(mgDf50)I or sir-2.1(ok434)IV
was reversed in presence of 2% glucose (Fig. 2b and 2d). In daf-16(mgDf50)I;daf-2(m65)
III, only in presence of 2% glucose, PWB (0.5 or 3.0%) induced a 40–50% reduction of the
fluorescence intensity in a dose-dependent manor (n=3, P<0.05) (Fig. 2c).
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3.2 Pharyngeal pumping rate (PPR)
The PWB treatment dose-dependently elevated the PPR in N2 (0.5, 1.0, or 3.0%, P<0.05)
(Fig. 3a, 3e), daf-16(mgDf50)I (Fig. 3b, 3f), daf-16(mgDf50)I;daf-2(m65)III (Fig. 3c, 3g),
or sir-2.1(ok434)IV (Fig. 3d, 3h) (n=20animals/3 dishes, P<0.05) with or without additional
2% glucose.
3.3 Lipid metabolism gene expression
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PWB feeding (0.5, 1, and 3%) dose-dependently reduced mRNA expression of cpt-1 (20–
30%), cpt-2 (30–40%), ckr-1 (30–40%), and gcy-8 (30–50%) in N2. The reduction was
observed in daf-16 deficient mutant as cpt-1 (30%), cpt-2 20–30%, ckr-1 (40%), and gcy-8
(40%). In daf-16/daf-2 mutant, cpt-1 was reduced by 30% while other three mRNA
expressions were elevated by cpt-2 (50%), ckr-1 (70–60%), and gcy-8 (80%). Although
there was a 20% reduction in gcy-8, feeding did not change the other three mRNA
expressions in the sir-2.1 mutant. In presence of glucose, however, these mRNA expressions
were increased in N2 by 10% and in the mutant daf-16 by 40%, while mRNA expression
was reduced in the mutant sir-2.1 by 50% after an initial increase of 30% and in the daf-16/
daf-2 by 10–50% after an initial reduction of 40–60% (P<0.05, Fig. 4).
3.4 Principal component analyses (PCA)
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Two factors explained the results of PCA. IFD has a strong negative effect with factor 1 in
N2, while it has weak relationship with factor 1 in other strains. IFD has a strong positive
relationship with factor 2 in daf-16, daf-16/daf-2, and sir-2.1 null mutants. PPR slope has a
strong negative relationship with factor 2 in daf-16/daf-2, and sir-2.1 null mutants, but there
was a strong positive relationship with factor 1 in daf-16 mutant. IFD and PPR have an
inverse relationship in all strains. cpt-1, ckr-1, gcy-8, and cpt-2 have strong positive
relationship with factor 1 but these 4 genes have an indirect relationship with factor 2 (Fig.
5).
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4. Discussion
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PWB (3%) induced significant reductions of Nile Red fluorescent intensity representing
intestinal fat deposition (IFD) in N2 (40%), sir-2.1(ok434)IV (30%) and daf-16(mgDf50)I
(25%) deficient mutants, but not in the daf-16(mgDf50)I;daf-2(m65)III deficient mutant.
The pharyngeal pumping rate (PPR) was elevated with all varieties of animals fed PWB. On
the contrary, reduced fluorescence intensity and elevated PPR were detected in daf-16/
daf-2(m65)III deficient mutant in the presence of an additional 2% glucose. PWB reduced
cpt-1, cpt-2, ckr-1, and gcy-8, which was reversed in sir-2.1 deficient mutant suggesting that
the major pathway of this effect is mediated by sir-2.1. It appeared that glucose reversed the
effect of PWB in the N2. Dissimilarly, daf-16 deficient had only a reduction of cpt-1 with
elevations on cpt-2, ckr-1, and gcy-8, all of which had an initial reduction. Additional
glucose augmented the PWB effects to a greater degree than in N2. Thus, daf-16 seemed
playing an inhibitory role on lipid and glucose metabolism. PWB had similar effects in
daf-16/daf-2 mutant as in N2. Unlike N2, the effect of additional glucose in daf-16/daf-2
mutant was eliminated by an initial increase in cpt-2, ckr-1, and gcy-8 followed by further
reduction. These findings indicated that daf-2 mediated the PWB effect but to a lesser degree
than sir-2, and facilitated glucose metabolism.
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Hyperlipidaemia is often co-existent with hyperglycaemia. Insulin-resistance induces
hyperglycaemia in rodent diabetes due to an increased peroxisome proliferator activated
receptor-α (PPARα) (Hostetler, Huang, Kier, & Schroeder, 2008). Deletion of nuclear
hormone receptor-49 (nhr-49), a homologue of PPARα in C. elegans, prevents
hyperlipidaemia and restores insulin-sensitivity comparable to that seen in PPARα null mice
(Atherton, Jones, Malik, Miska, & Griffin, 2008). In the current study, the PWB (3.0%)
induced more than a 40% reduction in the IFD, which was daf-16 or sir-2.1 dependent since
the effect was not seen in the daf-16/daf-2 mutant. The effect of reducing or not reducing
insulin sensitivity in the treatment groups described above was reversed when decreased
insulin-sensitivity was created by excessive glucose, and produced IFD reduction in daf-16/
daf-2 mutant insulin-resistance model. Since daf-16 has a central role in mediating the
downstream insulin signalling pathways and is the major target of the daf-2 pathway which
negatively regulates daf-16 (Kenyon, Chang, Gensch, Rudner, & Tabtiang, 1993; Lee,
Murphy, & Kenyon, 2009), possibly, PWB/β-glucans indirectly affected insulin-sensitivity
by affecting hyperglycaemia impaired lipid metabolism and served as a unique functional
food in addition to providing a source of RS. daf-2 is the only gene that encodes the insulin/
IGF-1 like receptor in C. elegans and the genes governing lipid metabolism do not
necessarily overlap with genes governing the aging process (Zheng & Greenway, 2012). We
found that neither sir-2.1 nor daf-16 was required for the PWB diet to reduce IFD. Due to
increased fat oxidation (with decreased RQ) and increased energy expenditure (Keenan et
al., 2006; Shen et al., 2009; Zhou et al., 2008), rodents that received RS had significantly
greater body fat reduction with continually elevated serum levels of the hormones PYY and
GLP-1 rather than peaks of these hormones in serum only after food consumption to signal
satiety (Keenan et al., 2006; Zhou et al., 2008). In agreement with the rodent studies, the
reduced IFD suggested an increased fat oxidation and increased energy expenditure rather
than an augmented satiety or reduced food intake. Glucose appeared to increase gcy-8 gene
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expression which promotes fat storage. This effect is lost in the presence of the sir-2.1
deficient mutant or with the lack of daf-2/daf-16, which suggest that the additional glucose
induced insulin resistance is dependent on daf-2 pathway and is suppressed by sir-2.1. The
other genes do not seem to play much of a role, but the small increase in cpt-2 with glucose
is reversed in sir-2.1 deficient mutant and the lack of both daf-2/daf-16. Since cpt-2 gene
expression in the daf-16 deficient mutant did not change, the effect of glucose on cpt-2 was
thought to be through daf-2 and that sir-2.1 inhibited that effect.

Author Manuscript

Extra glucose reduces C. elegans lifespan which may be independent of insulin-sensitivity
and changes in body fat. As indicated by a surrogate marker of aging PPR, PWB sustained
healthspan or lifespan. However, the PPR was not increased and was reduced with aging
when an additional 2% glucose was added to all the strains tested except the daf-16/daf-2
deficient mutant. Like IFD, the effect of PWB on PPR was reversed in the daf-16/daf-2
deficient mutant with addition of glucose suggesting an independent mechanism which may
involve a pathway outside of daf-2 or daf-2/daf-16 (Engelmann & Pujol, 2011; Zheng &
Greenway, 2012), or that absence of the daf-2 promoted insulin sensitivity despite high
levels of glucose. The PPR was dose-dependently elevated in all but the daf-2/daf-16 mutant
indicating a dependency on daf-2 or daf-2/daf-16 as their absence eliminated the elevation of
PPR. The sir-2.1 gene is related to the co-regulator/genes (Kyrylenko, Kyrylenko, Suuronen,
& Salminen, 2003) and is partially responsible for aging in C. elegans (Houthoofd,
Braeckman, Johnson, & Vanfleteren, 2003; Lakowski & Hekimi, 1998). Apparently, the
effect of improved healthspan or lifespan was independent of sir-2.1 in the present study,
which was more robust than in the daf-16 mutant. The daf-2/daf-16 mutant showed either no
change or a minor change in PPR suggested the effect was insulin/IGF-1 like receptor
pathway dependent, which was consistently absent in daf-16 mutant.
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5. Conclusions
Our data demonstrated that PWB reduced IFD, decreased insulin-resistance, and improved
healthspan or lifespan in the C. elegans model system which appeared to be primarily
mediated via sir-2.1, daf-16, and daf-16/daf-2. C. elegans is an attractive in vivo animal
model for initial studies of nutrition interventions prior to confirmation in higher animal
species. The identified optimal functional food components may be incorporated in various
ways into daily diet, because these are already known to have acceptability as food, and have
been tested in clinical trials. A broader test of other sources of the functional components of
PWB, such as, β-glucan, may provide more advantageous weight loss and obesity
prevention. This could result in future improvements in public health.
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Highlights
•

Prowashonupana barley (PWB) is rich in β-glucan and dietary fermentable
fiber.

•

PWB consumption reduced intestinal fat deposition in the C. elegans model
organism.

•

PWB consumption improved healthspan in C. elegans.

•

PWB may help to reduce the world-wide obesity epidemic and the cost of
health care.
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Fig. 1.

Intestinal fat deposition (IFD) was significantly reduced in the C. elegans (N2) that received
the Prowashonupana barley (PWB, 0.5% or 3%) compared to a control group. a) IFD stained
by Nile red in control animals. b) IFD stained by Nile red in animals that received the PWB
(0.5% or 3%). c) Fluorescence intensity of Nile red was reduced in the PWB treated
animals. d) The effect of PWB on fluorescence intensity of Nile red reduction was reversed
in the presence of 2% glucose.
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Fig. 2.

Intestinal fat deposition (IFD) was reduced in mutant C. elegans. a) N2 Fluorescence
intensity of Nile red was reduced in the Prowashonupana barley (PWB, 0.5%, 1%, or 3%)
treated animals. The fluorescence intensity of Nile red reduced by PWB treated animals was
reversed in the presence of 2% glucose. b) daf-16(mgDf50)I: The fluorescence intensity of
Nile red reduced by PWB treated animals was no different compared with control animals
with or without glucose. c) daf-16(mgDf50)I;daf-2(m65)III: Fluorescence intensity of Nile
red was not reduced in the PWB (0.5% or 3%) treated animals. PWB treatment reduced Nile
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red fluorescence intensity in the presence of 2% glucose. d) sir-2.1(ok434)IV: Fluorescence
intensity of IFD stained by Nile red in animals that received the PWB (0.5%, 1%, or 3%).
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Fig. 3.

Pharyngeal pumping rate (PPR) of C. elegans was reduced in all groups with aging. An
elevation of the PPR was observed in animals that received the Prowashonupana barley
(PWB) in a) N2 (P<0.05), b) daf-16(mgDf50)I groups (P<0.05), c)
daf-16(mgDf50)I;daf-2(m65) III (P<0.05) or d) sir-2.1(ok434)IV (P<0.05). Similar results
were observed in the presence of glucose in e) N2 (P<0.05), f) daf-16(mgDf50)I groups
(P<0.05), g) daf-16(mgDf50)I;daf-2(m65) III (P<0.05) or h) sir-2.1(ok434)IV (P<0.05).
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Fig. 4.

Prowashonupana barley (PWB) dose-dependently altered mRNA expressions of cpt-1, cpt-2,
ckr-1, and gcy-8 in the C. elegans model. a) Reduced in N2 and was reversed by additional
glucose; b) Elevated in daf-16 mutant with reduction on cpt-1 with further augmentation by
glucose; and c) Decreased in daf-16/daf-2 mutant and further reduced by glucose with an
initial increase except cpt-1; d) Did not change in sir-2.1 mutant while further reduced in
presence of glucose.
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Fig. 5.

Principal component analyses (PCA) showed the relationships of the lipid metabolic related
mRNAs (ckr-1, cpt-1, cpt-2, and gcy-8), pharyngeal pumping rate (PPR) slope, and
intestinal fat deposition (IFD) with two strong factors.
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Nutritional data of Prowashonupana barley (Sustagrain® Barley1), reported on a 100g basis.
Content

Quantity (g)

Content

Calories

390 kCal

Vitamin A

Calories from Fat

60 kCal

Quantity (mg)
0 IU

Vitamin C

0

Fat

6.5

Sodium

12

Saturated Fat

1.8

Calcium

33

Iron

3.6

Cholesterol
Carbohydrates

0

Vitamin B1 (Thiamin)

0.6

Total Dietary Fiber

64.3
30

Vitamin B2 (Riboflavin)

0.3

Beta glucan

15

Vitamin B3 (Niacin)

4.6

Soluble Fiber

12

Potassium

452

Protein

18

Zinc

2.8
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1
http://www.ardentmills.com/uploads/Ardent_Mills_Sustagrain.pdf
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10
0
0

OP50 (2×109 cfu/ml, µl)

PWB (5%, µl)

Glucose (50%, µl)

0

0

5

10

0.5

0

10

10

1

0

30

10

3

Without glucose

2

0

10

0

2

5

10

0.5

2

10

10

1

With glucose

Dosage (%)

2

30

10

3
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Treatments
(50µl)
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Protocol of experiment
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65

643

Carbohydrate
180

300

Total dietary fiber

Fat

150

Beta-glucan

Protein

PWB diet (mg/ml)

5.0

37.5

7.5

-

-

OP50 (mg/ml)

0.250

1.875

0.375

0.000

0.000

0

0.413

2.325

1.983

0.018

0.012

0.5%

0.575

2.775

3.590

0.037

0.023

1%

1.225

4.575

10.020

0.110

0.069

3%

PWB treatment (mg/plate)
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